Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL22551099

N.O=C(CC(C(=O)OC1CCCCC1)S(=O)(=O)O)OC1CCCCC1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
NAAA Q02083 2/20 0.41
HTT P42858 2/20 0.40
CYP19A1 P11511 3/20 0.38
EPHX1 P07099 2/20 0.37
CACNA1B Q00975 4/20 0.34
STS P08842 3/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
RECQL P46063 1/20 0.33
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL66513 0.98 CYP2C19 (0.46) CYP2C19L3MBTL1NAAAHTTCYP19A1
SCHEMBL31016394 0.97 CYP2C19 (0.45) CYP2C19L3MBTL1NAAAHTTCYP19A1
SCHEMBL6939900 0.97 CYP2C19 (0.45) CYP2C19L3MBTL1NAAAHTTCYP19A1
SCHEMBL472797 0.97 CYP2C19 (0.45) CYP2C19L3MBTL1NAAAHTTCYP19A1
SCHEMBL10172886 0.97 CYP2C19 (0.44) CYP2C19L3MBTL1NAAAHTTCYP19A1
SCHEMBL2012228 0.85 L3MBTL1 (0.54) CYP2C19L3MBTL1NAAAHTTCYP19A1
SCHEMBL3911806 0.85 L3MBTL1 (0.43) CYP2C19L3MBTL1NAAAHTTCYP19A1
SCHEMBL472798 0.84 CYP2C19 (0.43) CYP2C19L3MBTL1NAAAHTTCYP19A1
Potassium Ion SCHEMBL6939903 0.84 CYP2C19 (0.43) CYP2C19L3MBTL1NAAAHTTCYP19A1
SCHEMBL863257 0.83 L3MBTL1 (0.42) CYP2C19L3MBTL1NAAAHTTCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3723716-B1 KIT FOR PREPARING A BODY TREATMENT PRODUCT HENKEL AG & CO KGAA (DE) 2026-05-13 EP disclosed
WO-2025097290-A1 COMPOSITION AND METHOD USING THE SAME L'OREAL (FR) 2025-05-15 WO disclosed
US-20240390258-A1 FOAMING COMPOSITION L'OREAL (FR) 2024-11-28 US disclosed
EP-4422593-A1 FOAMING COMPOSITION L'OREAL (FR) 2024-09-04 EP disclosed
CN-118043029-A Foaming composition 莱雅公司 2024-05-14 CN disclosed
CN-117979945-A Composition for conditioning or caring for keratin materials 莱雅公司 2024-05-03 CN disclosed
CN-117844578-A Compositions comprising a peptidase and a biosurfactant 赢创运营有限公司 2024-04-09 CN disclosed
WO-2023133795-A1 COMPOSITION FOR CONDITIONING KERATIN FIBERS L'OREAL (FR) 2023-07-20 WO disclosed
CN-116419743-A Composition for conditioning and/or dyeing keratin fibres 莱雅公司 2023-07-11 CN disclosed
WO-2023044899-A1 FOAMING COMPOSITION L'OREAL (FR) 2023-03-30 WO disclosed
WO-2023044666-A1 COMPOSITION FOR CONDITIONING OR CARING FOR KERATIN MATERIALS L'OREAL (FR) 2023-03-30 WO disclosed
WO-2022068473-A1 COMPOSITION FOR CONDITIONING AND/OR DYEING KERATIN FIBERS L'OREAL (FR) 2022-04-07 WO disclosed
EP-3958832-A1 A COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUP FROM KERATIN MATERIALS L'Oreal (FR) 2022-03-02 EP disclosed
CN-113727693-A Composition for cleaning and/or removing make-up from keratin materials 莱雅公司 2021-11-30 CN disclosed
EP-3723716-A1 KIT FOR PRODUCING A BODY CARE COMPOSITION Henkel AG & Co. KGaA (DE) 2020-10-21 EP disclosed
CN-111432786-A Body care agent preparation kit 汉高股份有限及两合公司 2020-07-17 CN disclosed
CN-107429199-A Compositions comprising peptidases and biosurfactants 赢创德固赛有限公司 2017-12-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240390258-A1 FOAMING COMPOSITION SGMS1, SGMS2, SMURF1 CYP2C19 4593/4885L3MBTL1 4455/4885NAAA 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.